ARTICLE

FindCenter AddIcon

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

By Yasemin Saplakoglu — 2019

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Read on www.livescience.com

FindCenter Post-Image

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.

Article
Tanya Lewis
2020
FindCenter AddIcon
FindCenter Post-Image

Can Psychedelic Experiences Cure Alcohol Addiction?

A new study hints at a novel and promising treatment for alcohol use disorder.

Article
Mark Travers
2019
FindCenter AddIcon
FindCenter Post-Image

LSD May Help Treat Alcoholism

The psychedelic drug LSD can help people with alcoholism quit or cut back their drinking, according to a new analysis of data originally collected in the 1960s. The study adds to a renaissance of research interest in mind-expanding medications for psychiatric disorders.

Article
Maia Szalavitz
2012
FindCenter AddIcon
FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Article
Michael Pollan
2018
FindCenter AddIcon
FindCenter Post-Image

Not So Fast on Magic Mushrooms

Only a few days ago, millions of Americans probably had never heard of psilocybin, the active agent in psychedelic mushrooms, but thanks to Denver, it is about to get its moment in the political sun.

Article
Michael Pollan
2019
FindCenter AddIcon
FindCenter Post-Image

Experiences of ‘Ultimate Reality’ or ‘God’ Confer Lasting Benefits to Mental Health

In a survey of thousands of people who reported having experienced personal encounters with God, researchers report that more than two-thirds of self-identified atheists shed that label after their encounter, regardless of whether it was spontaneous or while taking a psychedelic.

Article
Johns Hopkins Medicine
2019
FindCenter AddIcon
FindCenter Post-Image

Roland Griffiths: 5 Fast Facts You Need to Know

Roland Griffiths is a Johns Hopkins University professor, researcher and expert in the field of pharmacology. He is best known for his research into the beneficial effects psilocybin on cancer patients.

Article
Alyssa Choiniere
2019
FindCenter AddIcon
FindCenter Post-Image

DMT Models the Near-Death Experience

Near-death experiences (NDEs) are complex subjective experiences, which have been previously associated with the psychedelic experience and more specifically with the experience induced by the potent serotonergic, N,N-Dimethyltryptamine (DMT).

Article
Christopher Timmermann, Leor Roseman, Luke Williams, David Erritzoe, Charlotte Martial, Héléna Cassol, Steven Laureys, David Nutt and Robin Carhart-Harris
2018
FindCenter AddIcon
FindCenter Post-Image

For the First Time, Scientists Have Imaged the Brain on LSD

The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.

Article
Victoria Turk
2016
FindCenter AddIcon
FindCenter Post-Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

Article
Amanda Feilding
2017
FindCenter AddIcon

EXPLORE TOPIC

Psilocybin